via NYU
COVID-19 Severity Score, Built with Data from China and New York City, Can Help Clinicians Identify the Most At-Risk Patients
A new mobile app can help clinicians determine which patients with the novel coronavirus (COVID-19) are likely to have severe cases. Created by researchers at NYU College of Dentistry, the app uses artificial intelligence (AI) to assess risk factors and key biomarkers from blood tests, producing a COVID-19 “severity score.”
Current diagnostic tests for COVID-19 detect viral RNA to determine whether someone does or does not have the virus—but they do not provide clues as to how sick a COVID-positive patient may become.
“Identifying and monitoring those at risk for severe cases could help hospitals prioritize care and allocate resources like ICU beds and ventilators. Likewise, knowing who is at low risk for complications could help reduce hospital admissions while these patients are safely managed at home,” said John T. McDevitt, PhD, professor of biomaterials at NYU College of Dentistry, who led the research.
“We want doctors to have both the information they need and the infrastructure required to save lives. COVID-19 has challenged both of these key areas.”
Creating a Severity Score
Using data from 160 hospitalized COVID-19 patients in Wuhan, China, the researchers identified four biomarkers measured in blood tests that were significantly elevated in patients who died versus those who recovered: C-reactive protein (CRP), myoglobin (MYO), procalcitonin (PCT), and cardiac troponin I (cTnI). These biomarkers can signal complications that are relevant to COVID-19, including acute inflammation, lower respiratory tract infection, and poor cardiovascular health.
The researchers then built a model using the biomarkers as well as age and sex, two established risk factors. They trained the model using a machine learning algorithm, a type of AI, to define the patterns of COVID-19 disease and predict its severity. When a patient’s biomarkers and risk factors are entered into the model, it produces a numerical COVID-19 severity score ranging from 0 (mild or moderate) to 100 (critical).
The model was validated using data from 12 hospitalized COVID-19 patients from Shenzhen, China, which confirmed that the model’s severity scores were significantly higher for the patients that died versus those who were discharged. These findings are published in Lab on a Chip, a journal of the Royal Society of Chemistry.
As New York City emerged as the epicenter of the pandemic, the researchers further validated the model using data from more than 1,000 New York City COVID-19 patients. To make the tool available and convenient for clinicians, they developed a mobile app that can be used at point-of-care to quickly calculate a patient’s severity score.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19 disease severity
- Some States Are Reporting ‘Breakthrough’ Cases of COVID-19—Here’s What That Meanson March 4, 2021 at 3:14 pm
The Minnesota Department of Health announced on March 2 that it is investigating several “breakthrough” cases of COVID-19 that have occurred in the state. Officials said in a health advisory that the ...
- Most pro athletes who got COVID-19 didn’t develop heart inflammationon March 4, 2021 at 3:03 pm
Few professional athletes developed heart inflammation after a bout of COVID-19, but how the findings relate to the general public isn’t clear.
- Clot waveform of APTT has abnormal patterns in subjects with COVID-19on March 4, 2021 at 1:55 pm
In this study, we performed clot waveform analyses to investigate whether specific modulations are observed in COVID-19 subjects. We analyzed the second derivative of the absorbance in routine APTT ...
- Study shows less than 1% of pro athletes infected by COVID-19 also developed inflammatory heart diseaseon March 4, 2021 at 8:43 am
A recent study has revealed that out of 789 professional athletes infected with COVID-19, only five of them had inflammatory heart disease.
- Could GI Symptoms in COVID-19 Portend Better Prognosis?on March 4, 2021 at 7:02 am
Pro-inflammatory response and mortality appeared to be reduced in hospitalized COVID-19 patients with gastrointestinal manifestations, suggesting that the GI tract may mitigate SARS-CoV-2 inflammation ...
Go deeper with Google Headlines on:
COVID-19 disease severity
Go deeper with Bing News on:
COVID-19
- Fauci calls loosening Covid-19 restrictions inexplicable as variants threaten another surgeon March 4, 2021 at 3:32 pm
The United States shouldn't ease restrictions in place to prevent Covid-19 before the number of new coronavirus cases falls below 10,000 daily, "and maybe even considerably less than that," Dr.
- Fauci: US shouldn't relax Covid-19 restrictions until new daily cases are below 10,000on March 4, 2021 at 3:32 pm
The United States shouldn't ease restrictions in place to prevent Covid-19 before the number of new coronavirus cases falls below 10,000 daily, "and maybe even considerably less than that," Dr.
- San Diego Zoo vaccinates apes against COVID-19on March 4, 2021 at 3:31 pm
Nine great apes at the San Diego Zoo are the first non-human primates to receive an experimental COVID-19 vaccine, zoo officials said Thursday.
- Connecticut Rolls Back Covid-19 Business Restrictionson March 4, 2021 at 3:14 pm
The state is lifting capacity caps on offices, retail shops, restaurants and other businesses, but is keeping its mask mandate in effect.
- Coronavirus live: four stillbirths in Ireland potentially linked to Covid-19; UK investigates new varianton March 4, 2021 at 3:07 pm
Irish health officials investigating placental infections that led to stillbirths; Sixteen cases of new variant identified so far ...